Live cell therapy as potential risk factor for Q fever

1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

During an outbreak of Q fever in Germany, we identified an infected sheep flock from which animals were routinely used as a source for life cell therapy (LCT), the injection of fetal cells or cell extracts from sheep into humans. Q fever developed in 7 LCT recipients from Canada, Germany, and the United States.

Cite

CITATION STYLE

APA

George, M., Reich, A., Cussler, K., Jehl, H., & Burckhardt, F. (2017, July 1). Live cell therapy as potential risk factor for Q fever. Emerging Infectious Diseases. Centers for Disease Control and Prevention (CDC). https://doi.org/10.3201/eid2307.161693

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free